Maucher A, von Angerer E, Hampl R, Stárka L
Institut für Pharmazie, Universität Regensburg, Germany.
Endocr Regul. 1994 Mar;28(1):23-9.
Epitestosterone has been shown previously to counteract the testosterone activity in some experimental models. In the present study the activity of epitestosterone in an in vitro model of human LNCaP/FCS prostate cells and in vitro in Dunning R 3327-GH rat prostate carcinoma was tested. In LNCaP/FGC cells cultivated with fetal calf serum (FCS) treated with dextran-coated charcoal epitestosterone displayed rather androgenic than antiandrogenic properties, whereas the cultivation with native FCS resulted in a very weak inhibition of tumour cell growth with epitestosterone in higher concentration. The growth of Dunning R 3327-GH carcinoma of prostate was very weakly enhanced by epitestosterone alone as late as at the end of the 5-week experiment. Epitestosterone did not significantly inhibit the testosterone stimulated tumour growth.
此前已有研究表明,在某些实验模型中,表睾酮可抵消睾酮的活性。在本研究中,对表睾酮在人LNCaP/FCS前列腺细胞体外模型以及邓宁R 3327-GH大鼠前列腺癌体外模型中的活性进行了测试。在用葡聚糖包被活性炭处理的胎牛血清(FCS)培养的LNCaP/FGC细胞中,表睾酮表现出雄激素特性而非抗雄激素特性,而用天然FCS培养时,较高浓度的表睾酮对肿瘤细胞生长的抑制作用非常微弱。仅表睾酮对邓宁R 3327-GH前列腺癌生长的促进作用很弱,直到5周实验结束时才有所体现。表睾酮并未显著抑制睾酮刺激的肿瘤生长。